Greta Carioli1, Matteo Malvezzi1, Teresa Rodriguez2, Paola Bertuccio1, Eva Negri3, Carlo La Vecchia1. 1. Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy. 2. Navarra Health Service, Pamplona, Spain. 3. Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy. Electronic address: eva.negri@unimi.it.
Abstract
OBJECTIVES: We analyzed trends in mortality from breast cancer in women in 36 European countries and the European Union (EU) over the period 1970-2014, and predicted numbers of deaths and rates to 2020. MATERIALS AND METHODS: We derived breast cancer death certification data and population figures from the World Health Organization and Eurostat databases. We obtained 2020 estimates using a joinpoint regression model. RESULTS: Overall, EU breast cancer mortality rates (world standard) declined from 17.9/100,000 in 2002 to 15.2 in 2012. The predicted 2020 rate is 13.4/100,000. The falls were largest in young women (20-49 years, -22% between 2002 and 2012). Within the EU, declines were larger in the United Kingdom (UK) and other northern and western European countries than in most central and eastern Europe. The UK has the second lowest predicted breast cancer mortality rate in 2020 (after Spain), starting from the highest one in 1970. Breast cancer mortality is predicted to rise in Poland, where the predicted 2020 rate is 15.3/100,000. We estimated that about 32,500 breast cancer deaths will be avoided in 2020 in the EU as compared to the peak rate of 1989, and a total of 475,000 breast cancer deaths over the period 1990-2020. CONCLUSION: The overall favourable breast cancer mortality trends are mainly due to a succession of improvements in the management and treatment of breast cancer, though early diagnosis and screening played a role, too. Improving breast cancer management in central and eastern Europe is a priority.
OBJECTIVES: We analyzed trends in mortality from breast cancer in women in 36 European countries and the European Union (EU) over the period 1970-2014, and predicted numbers of deaths and rates to 2020. MATERIALS AND METHODS: We derived breast cancer death certification data and population figures from the World Health Organization and Eurostat databases. We obtained 2020 estimates using a joinpoint regression model. RESULTS: Overall, EU breast cancer mortality rates (world standard) declined from 17.9/100,000 in 2002 to 15.2 in 2012. The predicted 2020 rate is 13.4/100,000. The falls were largest in young women (20-49 years, -22% between 2002 and 2012). Within the EU, declines were larger in the United Kingdom (UK) and other northern and western European countries than in most central and eastern Europe. The UK has the second lowest predicted breast cancer mortality rate in 2020 (after Spain), starting from the highest one in 1970. Breast cancer mortality is predicted to rise in Poland, where the predicted 2020 rate is 15.3/100,000. We estimated that about 32,500 breast cancer deaths will be avoided in 2020 in the EU as compared to the peak rate of 1989, and a total of 475,000 breast cancer deaths over the period 1990-2020. CONCLUSION: The overall favourable breast cancer mortality trends are mainly due to a succession of improvements in the management and treatment of breast cancer, though early diagnosis and screening played a role, too. Improving breast cancer management in central and eastern Europe is a priority.
Authors: Raffaele Giusti; Emanuela Scarpi; Katia Cannita; Rosa Rita Silva; Marco Filetti; Marco Mazzotta; Corrado Ficorella; Andrea Botticelli; Marco Maltoni; Paolo Marchetti; Giampiero Porzio; Lucilla Verna Journal: Support Care Cancer Date: 2019-06-08 Impact factor: 3.603
Authors: Bing Dong; Xiaoxing Yin; Han Xu; Kun Zhou; Longzhi Li; Baoxing Tian; Rongrong Cui Journal: Am J Transl Res Date: 2022-04-15 Impact factor: 3.940
Authors: Bernd Uhl; Laura A Mittmann; Julian Dominik; Roman Hennel; Bojan Smiljanov; Florian Haring; Johanna B Schaubächer; Constanze Braun; Lena Padovan; Robert Pick; Martin Canis; Christian Schulz; Matthias Mack; Ewgenija Gutjahr; Peter Sinn; Jörg Heil; Katja Steiger; Sandip M Kanse; Wilko Weichert; Markus Sperandio; Kirsten Lauber; Fritz Krombach; Christoph A Reichel Journal: EMBO Mol Med Date: 2021-05-16 Impact factor: 12.137
Authors: Laura Biganzoli; Fatima Cardoso; Marc Beishon; David Cameron; Luigi Cataliotti; Charlotte E Coles; Roberto C Delgado Bolton; Maria Die Trill; Sema Erdem; Maria Fjell; Romain Geiss; Mathijs Goossens; Christiane Kuhl; Lorenza Marotti; Peter Naredi; Simon Oberst; Jean Palussière; Antonio Ponti; Marco Rosselli Del Turco; Isabel T Rubio; Anna Sapino; Elzbieta Senkus-Konefka; Marko Skelin; Berta Sousa; Tiina Saarto; Alberto Costa; Philip Poortmans Journal: Breast Date: 2020-02-26 Impact factor: 4.380